Biorasi Revenue and Competitors
Estimated Revenue & Valuation
- Biorasi's estimated annual revenue is currently $62.9M per year.
- Biorasi's estimated revenue per employee is $201,000
Employee Data
- Biorasi has 313 Employees.
- Biorasi grew their employee count by -4% last year.
Biorasi's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Staff | Reveal Email/Phone |
3 | Head Global Feasibility | Reveal Email/Phone |
4 | VP Project Management | Reveal Email/Phone |
5 | SVP, People and Culture | Reveal Email/Phone |
6 | SVP Operations & Head Strategy | Reveal Email/Phone |
7 | SVP, Commercial Operations | Reveal Email/Phone |
8 | VP, Clinical Operations | Reveal Email/Phone |
9 | VP, Data Sciences and Biometrics | Reveal Email/Phone |
10 | VP, Medical and Scientific Affairs | Reveal Email/Phone |
Biorasi Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $33.8M | 125 | 15% | N/A | N/A |
What Is Biorasi?
Biorasi is a contract research organization (CRO) widely recognized for delivering success in complex clinical trials. This is possible through TALOS, an innovative operating model that unifies systems and teams with a powerful project management methodology to ensure high quality delivery. Overall, Biorasi balances power, time, acceptance, cost, and service level to optimize the delivery of clinical studies. With TALOS as our foundation, we leverage three elements to deliver success: - Full-service capabilities seamlessly integrated for high quality delivery - Global footprint across North America, Western and Eastern Europe, Asia, Australia, and Latin America, leveraging an optimal set of venues for every study - Therapeutic area expertise allowing optimized delivery of complex Phase I-IV studies Contact us now to learn more about how we can help you manage your most complex studies. http://www.biorasi.com/contact-us
keywords:N/AN/A
Total Funding
313
Number of Employees
$62.9M
Revenue (est)
-4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Biorasi News
Therapeutic Solutions International (OTCPK:TSOI) said it selected Biorasi as the contract research organization (CRO) to run a phase 3 trial...
Biorasi, a leading global full-service contract research organization (CRO), is proud to announce the achievement of ISO 9001:2015 certification. By earning this ISO accreditation, Biorasi has demonstrated dedication to the practice of quality assurance within the clinical trials industry and co ...
MIAMI--(BUSINESS WIRE)--Mar 2, 2021-- Biorasi, a leading global full-service contract research organization (CRO), has announced the appointment of Jimmy El Hokayem, Ph.D., head of the company’s Neurology and Regenerative Medicine Center of Excellence to the Scientific Advisory Board (SAB) for ...
Instead of simply doing more of what the primary CRO was doing on behalf of the sponsor, Biorasi leveraged their extensive patient network and Talos™ ...
Biorasi plans to scale several aspects of its global CRO business following a PE investment – and while it does not plan to “buy size,” smaller ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $82.4M | 314 | 28% | N/A |
#2 | $39.3M | 314 | 7% | N/A |
#3 | $78.9M | 314 | 25% | N/A |
#4 | $106.3M | 315 | 7% | N/A |
#5 | $39.6M | 317 | 7% | N/A |